798
Views
0
CrossRef citations to date
0
Altmetric
Editorial

The relative weak way and the absolute strong way to communicate risk information

ORCID Icon, & ORCID Icon

Figures & data

Figure 1. (A) Incidence rate of COVID-19 breakthrough infections in vaccinated individuals with the PfizerBioNTech and Moderna vaccines. The incidence rate of breakthrough infections with the PfizerBioNTech vaccine is about twice what the rate is for the Moderna vaccine. (B) Absolute risk increase in COVID-19 breakthrough infections in vaccinated individuals with the PfizerBioNTech and Moderna vaccines. Over one year, for every 100 people treated with PfizerBioNTech and Moderna vaccines, one additional breakthrough infections would be expected with the PfizerBioNTech vaccine than with the Moderna vaccine.

Figure 1. (A) Incidence rate of COVID-19 breakthrough infections in vaccinated individuals with the PfizerBioNTech and Moderna vaccines. The incidence rate of breakthrough infections with the PfizerBioNTech vaccine is about twice what the rate is for the Moderna vaccine. (B) Absolute risk increase in COVID-19 breakthrough infections in vaccinated individuals with the PfizerBioNTech and Moderna vaccines. Over one year, for every 100 people treated with PfizerBioNTech and Moderna vaccines, one additional breakthrough infections would be expected with the PfizerBioNTech vaccine than with the Moderna vaccine.

Figure 2. Incidence rate of individuals not acquiring COVID-19 breakthrough infections with the PfizerBioNTech and Moderna vaccine. The rate of vaccinated individuals not having a breakthrough infection is 98 per 100 person-years for PfizerBioNTech and 99 per 100 person-years for Moderna.

Figure 2. Incidence rate of individuals not acquiring COVID-19 breakthrough infections with the PfizerBioNTech and Moderna vaccine. The rate of vaccinated individuals not having a breakthrough infection is 98 per 100 person-years for PfizerBioNTech and 99 per 100 person-years for Moderna.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.